Allele frequency of CYP2C19 in a Portuguese population.

Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population. Br J Clin Pharmacol (2002) 1.30

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study. Eur J Clin Pharmacol (2005) 0.95

Implication of Xenobiotic Metabolizing Enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer (2008) 0.94

Genetic polymorphism of CYP2C19 in Maharashtrian population. Eur J Epidemiol (2007) 0.83

Genetic Polymorphism of Cytochrome p450 (2C19) Enzyme in Iranian Turkman Ethnic Group. Oman Med J (2013) 0.77

Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43

Nonpalpable breast lesions: correlation of stereotaxic large-core needle biopsy and surgical biopsy results. Radiology (1993) 2.58

Stereotactic breast biopsy of nonpalpable lesions: determinants of ductal carcinoma in situ underestimation rates. Radiology (2001) 1.40

Atypical ductal hyperplasia diagnosed at stereotactic breast biopsy: improved reliability with 14-gauge, directional, vacuum-assisted biopsy. Radiology (1997) 1.24

Interaction between smoking, GSTM1 deletion and colorectal cancer: results from the GSEC study. Biomarkers (2003) 0.92

Increased frequency of wild-type arylamine-N-acetyltransferase allele NAT2*4 homozygotes in Portuguese patients with colorectal cancer. Carcinogenesis (1998) 0.87

Glycerol increases the yield and activity of human phenylalanine hydroxylase mutant enzymes produced in a prokaryotic expression system. Mol Genet Metab (2001) 0.87

Population genetics of hyperphenylalaninaemia resulting from phenylalanine hydroxylase deficiency in Portugal. J Med Genet (1998) 0.85

Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Eur J Neurol (2007) 0.85

Glucocorticoid receptor-independent transcriptional induction of cytochrome P450 3A1 by metyrapone and its potentiation by glucocorticoid. Mol Pharmacol (1996) 0.85

Mutation analysis of phenylketonuria in south and central Portugal: prevalence of V388M mutation. Hum Mutat (1995) 0.81

Cloning and characterization of a novel CYP3A1 allelic variant: analysis of CYP3A1 and CYP3A2 sex-hormone-dependent expression reveals that the CYP3A2 gene is regulated by testosterone. Arch Biochem Biophys (1992) 0.81

In vitro biosynthesis of liver cytochrome P450 mature peptide sub-unit by translation of isolated poly(A)+ mRNA from normal and phenobarbital induced rats. Biochem Biophys Res Commun (1979) 0.80

Developmental changes in the constitutive and inducible expression of cytochrome P450 3A2. Biochem Pharmacol (1997) 0.80

N-acetyltransferase (NAT2) genotype and susceptibility of sporadic Alzheimer's disease. Pharmacogenetics (1999) 0.80

Critical amino-terminal segments in insertion of rat liver cytochrome P450 3A1 into the endoplasmic reticulum membrane. Experientia (1996) 0.79

The V388M mutation results in a kinetic variant form of phenylalanine hydroxylase. Mol Genet Metab (2000) 0.79

Cerebral hemorrhage and apoE. J Neurol (1999) 0.79

P450-catalyzed in-chain desaturation of valproic acid: isoform selectivity and mechanism of formation of Delta 3-valproic acid generated by baculovirus-expressed CYP3A1. Arch Biochem Biophys (1998) 0.79

Phenobarbital-mediated modulation of gene expression in rat liver. Analysis of cDNA clones. Eur J Biochem (1987) 0.78

Effect of dexamethasone and phenobarbital on run-on transcription rate and CYP3A mRNA concentration in rat liver: changes during development. Arch Biochem Biophys (1992) 0.78

Expression of a constitutive form of cytochrome P450 during rat-liver development and sexual maturation. Eur J Biochem (1988) 0.77

Age of onset in patients with Alzheimer's disease with different apoE genotypes. J Neurol Neurosurg Psychiatry (1998) 0.77

Absence of stimulation of poly(ADP-ribose) polymerase activity in patients predisposed to colon cancer. Br J Cancer (1998) 0.77

ADP-ribosylation of nuclear proteins is increased by phenobarbital. Identification of the ADP-ribosylated histone fractions in rat liver nuclei. FEBS Lett (1986) 0.77

Nuclear ADP-ribosyl transferase activity correlates with induction of P-450 monooxygenases by phenobarbital in rat liver microsomes. Eur J Biochem (1985) 0.77

Aging effects on hepatic NADPH cytochrome P450 reductase, CYP2B1&2, and polymeric immunoglobulin receptor mRNAs in male Fischer 344 rats. Exp Gerontol (1994) 0.77

The correlation of genotype and phenotype in Portuguese hyperphenylalaninemic patients. Mol Genet Metab (2000) 0.77

Differential regulation of the cytochrome P450 3A1 gene transcription by dexamethasone in immature and adult rat liver. Eur J Biochem (1995) 0.76

Identification of a functional glucocorticoid response element in the CYP3A1/IGC2 gene. DNA Cell Biol (1998) 0.76

Effect of rat developmental stage at initiation on the expression of biochemical markers during liver tumor promotion. Tumour Biol (1990) 0.75

Changes in rat serum ribonuclease during phenobarbital treatment. Biochem Pharmacol (1972) 0.75

Ribosomal and microsomal RNase activities in rat liver after methylcholanthrene administration. Biochem Pharmacol (1972) 0.75

Variation in rat serum alkaline RNase after experimentally induced hypothyroidism. Int J Biochem (1979) 0.75

Induction of alpha 2u globulin mRNA by phenobarbital in rat liver: characterization of a cDNA clone. Biochem Biophys Res Commun (1986) 0.75

The steroid antagonist RU38486 is metabolized by the liver microsomal P450 mono-oxygenases. Biochem Biophys Res Commun (1990) 0.75

Two IgM paraproteins differing in carbohydrate content in a patient with Waldenström's macroglobulinemia. Clin Chim Acta (1976) 0.75

Relative frequency of IVS10nt546 mutation in a Portuguese phenylketonuric population. Hum Mutat (1997) 0.75

RNase activities in blood serum of several vertebrates. Experientia (1973) 0.75

A possible role of liver microsomal alkaline ribonuclease in the stimulation of oxidative drug metabolism by phenobarbital, chlordane and chlorophenothane (DDT). Biochem Pharmacol (1971) 0.75

RNA from free and membrane-bound rat liver ribosomes. Bull Soc Chim Biol (Paris) (1970) 0.75